Current Practice of Autologous Hematopoietic Progenitor Cell Mobilization in Adult Patients with Multiple Myeloma And Lymphoma: The Results of A Survey From Turkish Hematology Research And Education Group (Threg)

dc.contributor.authorTekgunduz, Emre
dc.contributor.authorDemirkan, Fatih
dc.contributor.authorVural, Filiz
dc.contributor.authorGoker, Hakan
dc.contributor.authorOzdogu, Hakan
dc.contributor.authorKiki, Ilhami
dc.contributor.authorAydogdu, Ismet
dc.contributor.authorKaynar, Leylagul
dc.contributor.authorErkurt, Mehmet Ali
dc.contributor.authorCagirgan, Seckin
dc.contributor.authorBesisik, Sevgi
dc.contributor.authorDagdas, Simten
dc.contributor.authorKoca, Ebru
dc.contributor.authorKadikoylu, Gurhan
dc.contributor.authorGunduz, Eren
dc.contributor.authorYilmaz, Mehmet
dc.contributor.authorBekoz, Huseyin
dc.contributor.authorUral, Ali Ugur
dc.contributor.authorBasturk, Abdulkadir
dc.contributor.authorArat, Mutlu
dc.contributor.authorAlbayrak, Murat
dc.contributor.authorOzturk, Erman
dc.contributor.authorAkyol, Alev
dc.contributor.authorBolaman, Ali Zahit
dc.contributor.authorNevruz, Oral
dc.contributor.authorOzkan, Hasan Atilla
dc.contributor.authorOzgur, Gokhan
dc.contributor.authorAltuntas, Fevzi
dc.contributor.pubmedID29153305en_US
dc.date.accessioned2023-05-25T07:08:03Z
dc.date.available2023-05-25T07:08:03Z
dc.date.issued2017
dc.description.abstractAutologous hematopoietic cell transplantation (AHCT) is an established treatment option for adult patients presenting with multiple myeloma (MM), Hodgkin lymphoma (HL) and various subtypes of non-Hodgkin lymphoma (NHL) in upfront and/or relapsed/refractory disease settings. Although there are recently published consensus guidelines addressing critical issues regarding autologous hematopoietic progenitor cell mobilization (HPCM), mobilization strategies of transplant centers show high variability in terms of routine practice. In order to understand the current institutional policies regarding HPCM in Turkey and to obtain the required basic data for preparation of a national positional statement on this issue, Turkish Hematology Research and Education Group (ThREG) conducted a web-based HPCM survey. The survey was designed to include multiple-choice questions regarding institutional practice of HPCM in adults presenting MM, HL, and NHL. The representatives of 27 adult HCT centers participated to the study. Here we report the results of this survey shedding light on the real world experience in Turkey in terms of autologous HPCM mobilization strategies in patients presenting with MM and lymphoma. (C) 2017 Elsevier Ltd. All rights reserved.en_US
dc.identifier.endpage808en_US
dc.identifier.issn1473-0502en_US
dc.identifier.issue6en_US
dc.identifier.scopus2-s2.0-85033796844en_US
dc.identifier.startpage804en_US
dc.identifier.urihttp://hdl.handle.net/11727/9180
dc.identifier.volume56en_US
dc.identifier.wos000423246100009en_US
dc.language.isoengen_US
dc.relation.isversionof10.1016/j.transci.2017.11.010en_US
dc.relation.journalTRANSFUSION AND APHERESIS SCIENCEen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAutologous hematopoietic cell transplantationen_US
dc.subjectLymphomaen_US
dc.subjectMyelomaen_US
dc.subjectMobilizationen_US
dc.titleCurrent Practice of Autologous Hematopoietic Progenitor Cell Mobilization in Adult Patients with Multiple Myeloma And Lymphoma: The Results of A Survey From Turkish Hematology Research And Education Group (Threg)en_US
dc.typearticleen_US

Files

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: